文献速递冠心病

直接PCI治疗的STEMI患者10年死亡率与匹配一般人群的比较

10-Year Mortality After ST-Segment Elevation Myocardial Infarction Compared to the General Population.
PubMed 文献 · J Am Coll Cardiol · 2024-01-01

该研究基于西丹麦心脏登记,纳入2003年至2018年首次接受直接PCI的STEMI患者18818例,并按年龄和性别与一般人群按1:5匹配94090人。结果显示,0至30天超额死亡率为5.9%,31至90天仍存在超额死亡,但90天存活者的10年绝对超额死亡率仅为2.1个百分点(26.5% vs 24.5%)。

要点

  • 直接PCI治疗的STEMI患者早期(0-30天)超额死亡率高达5.9%。
  • 90天存活者的10年绝对超额死亡率仅为2.1个百分点。
  • 二级预防药物(他汀、抗血小板、β受体阻滞剂)使用率在10年随访中很高。

核心结论

  • 在高使用指南推荐治疗的情况下,直接PCI治疗的STEMI患者存活超过90天后,其10年死亡率仅比匹配的一般人群高约2%。

研究设计与样本

  • 基于西丹麦心脏登记的前瞻性队列研究,纳入2003年1月至2018年10月首次接受直接PCI的STEMI患者18818例,并按年龄和性别与一般人群1:5匹配94090人。

主要发现

  • 与匹配一般人群相比,STEMI患者0至30天超额死亡率为5.9%(6.0% vs 0.2%;HR 36.44;95%CI 30.86-43.04)。
  • 31至90天仍存在超额死亡(0.9% vs 0.4%;HR 2.43;95%CI 2.02-2.93)。
  • 90天存活者的10年绝对超额死亡率为2.1个百分点(26.5% vs 24.5%;HR 1.04;95%CI 1.01-1.08)。

临床怎么用

  • 对于直接PCI后存活出院的STEMI患者,应强调长期二级预防以进一步降低远期超额死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: ST-segment elevation myocardial infarction (STEMI) is associated with high early mortality. However, it remains unclear if patients surviving the early phase have long-term excess mortality. OBJECTIVES: This study aims to assess excess mortality in STEMI patients treated with primary percutaneous coronary intervention (PCI) compared with an age- and- sex-matched general population at landmark periods 0 to 30 days, 31 to 90 days, and 91 days to 10 years. METHODS: Using the Western Denmark Heart Registry, we identified first-time PCI-treated patients who had primary PCI for STEMI from January 2003 to October 2018. Each patient was matched by age and sex to 5 individuals from the general population. RESULTS: We included 18,818 patients with first-time STEMI and 94,090 individuals from the general population. Baseline comorbidity burden was similar in STEMI patients and matched individuals. Compared with the matched individuals, STEMI was associated with a 5.9% excess mortality from 0 to 30 days (6.0% vs 0.2%; HR: 36.44; 95% CI: 30.86-43.04). An excess mortality remained present from 31 to 90 days (0.9% vs 0.4%; HR: 2.43; 95% CI: 2.02-2.93). However, in 90-day STEMI survivors, the absolute excess mortality was only 2.1 percentage points at 10-year follow-up (26.5% vs 24.5%; HR: 1.04; 95% CI: 1.01-1.08). Use of secondary preventive medications such as statins, antiplatelet therapy, and beta-blockers was very high in STEMI patients throughout 10-year follow-up. CONCLUSIONS: In primary PCI-treated STEMI patients with high use of guideline-recommended therapy, patients surviving the first 90 days had 10-year mortality that was only 2% higher than that of a matched general population.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Thrane, Olesen, Thim, et al. 10-Year Mortality After ST-Segment Elevation Myocardial Infarction Compared to the General Population. J Am Coll Cardiol. 2024. PMID: 38897670. doi:10.1016/j.jacc.2024.04.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。